| Announce Date [Date of Effective Change] | Buyer/ Seller Name [Type*] | S/ W/ U ** | Bought/ (Sold) ('000) | Price ($) | After Trade | Note | |
|---|---|---|---|---|---|---|---|
| No. of Shares ('000) *** | % Held *** | ||||||
| 23/11/22 [21/11/22] |
KHOO SHIH WEE @ LAWRENCE KHOO [SSH] | S/U | (31,799) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 5,978,207.30 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) |
| 23/11/22 [21/11/22] |
LIM TET CHEN ROY [SSH] | S/U | (35,923) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 6,753,497.12 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) |
| 23/11/22 [21/11/22] |
HO SIEW HONG [SSH] | S/U | (41,267) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 7,758,215.36 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) |
| 22/11/22 [21/11/22] |
SIAN CHAY MEDICAL INSTITUTION [SSH] | S/U | (30,864) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): $5,802,469.04 Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest)The percentage of total number of voting shares immediately before and after this transaction is calculated based on the total issued share capital of 578,370,195 as at the date of this transaction. |
| 22/11/22 [21/11/22] |
AHS INVESTMENTS HOLDINGS PTE. LTD. [SSH] | S/U | (243,100) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 44,331,716 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest)AHS Investments Holdings Pte. Ltd. ("AHSIH") previously had a deemed interest in 7,293,000 ordinary shares held by Dr. Lim Cheok Peng ("Dr. Lim") under a right of first refusal granted by Dr. Lim to AHSIH in respect of the 7,293,000 ordinary shares held by him. Accordingly, under Section 4 of the Securities and Futures Act, AHSIH was deemed interested in the shares held by Dr. Lim. AHSIH understands that Dr. Lim had tendered the shares in acceptance of the take-over offer for the Listed Issuer, and the settlement date for the 7,293,000 ordinary shares tendered by Dr. Lim was 21 November 2022. The shareholders of AHSIH are Dr. Chin Pak Lin, Dr. Yue Wai Mun, Dr. Su Hsien Ching David and Dr. Tan Chyn Hong in equal proportions. Accordingly, each of Dr. Chin, Dr. Yue, Dr. Su and Dr. Tan is deemed interested in the shares that AHSIH is interested in by virtue of Section 4 of the SFA. |
| 22/11/22 [21/11/22] |
CHENG CHING LI [DIR] | S/U | (49,331) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Director/CEO (excluding brokerage and stamp duties): 9,270,379.26 Singapore Dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest)Dr Cheng Ching Li is deemed to have an interest in the 20,000 ordinary shares held by his spouse. |
| 22/11/22 [21/11/22] |
Chin Pak Lin [SSH] | S/U | (243,100) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 44,331,716 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) |
| 22/11/22 [21/11/22] |
Su Hsien Ching David [SSH] | S/U | (243,100) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 44,331,716 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) |
| 22/11/22 [21/11/22] |
Tan Chyn Hong [SSH] | S/U | (243,100) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 44,331,716 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) |
| 22/11/22 [21/11/22] |
Yue Wai Mun [SSH] | S/U | (243,100) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): 44,331,716 Singapore dollars Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest) |
| 22/11/22 [21/11/22] |
CHIN PAK LIN [DIR] | S/U | (243,100) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest)AHS Investments Holdings Pte. Ltd. ("AHSIH") has a direct interest in 235,807,000 ordinary shares in the Listed Issuer. The shareholders of AHSIH are Dr Chin Pak Lin, Dr Yue Wai Mun, Dr Su Hsien Ching David and Dr Tan Chyn Hong in equal proportions. Accordingly, each of Dr Chin Pak Lin, Dr Yue Wai Mun, Dr Su Hsien Ching David and Dr Tan Chyn Hong is deemed interested in the ordinary shares that AHSIH is interested in by virtue of Section 4 of the Securities and Futures Act. AHSIH previously had a deemed interest in 7,293,000 ordinary shares held by Dr. Lim Cheok Peng ("Dr. Lim") under a right of first refusal granted by Dr. Lim to AHSIH in respect of the 7,293,000 ordinary shares held by him. Accordingly, under Section 4 of the Securities and Futures Act, AHSIH was deemed interested in the shares held by Dr. Lim. AHSIH understands that Dr. Lim had tendered the shares in acceptance of the take-over offer for the Listed Issuer, and the settlement date for the 7,293,000 ordinary shares tendered by Dr. Lim was 21 November 2022. |
| 22/11/22 [21/11/22] |
YUE WAI MUN [DIR] | S/U | (243,100) | - | NA | NA | Note
Remarks
Acceptance of take-over offer for Listed Issuer Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 0 (Deemed Interest)AHS Investments Holdings Pte. Ltd. ("AHSIH") has a direct interest in 235,807,000 ordinary shares in the Listed Issuer. The shareholders of AHSIH are Dr Chin Pak Lin, Dr Yue Wai Mun, Dr Su Hsien Ching David and Dr Tan Chyn Hong in equal proportions. Accordingly, each of Dr Chin Pak Lin, Dr Yue Wai Mun, Dr Su Hsien Ching David and Dr Tan Chyn Hong is deemed interested in the ordinary shares that AHSIH is interested in by virtue of Section 4 of the Securities and Futures Act. AHSIH previously had a deemed interest in 7,293,000 ordinary shares held by Dr. Lim Cheok Peng ("Dr. Lim") under a right of first refusal granted by Dr. Lim to AHSIH in respect of the 7,293,000 ordinary shares held by him. Accordingly, under Section 4 of the Securities and Futures Act, AHSIH was deemed interested in the shares held by Dr. Lim. AHSIH understands that Dr. Lim had tendered the shares in acceptance of the take-over offer for the Listed Issuer, and the settlement date for the 7,293,000 ordinary shares tendered by Dr. Lim was 21 November 2022. |
| 23/12/21 [21/12/21] |
Sian Chay Medical Institution [SSH] | S/U | 30,864 | - | 30,864 | 5.34 | Note
Remarks
Acquisition of Securities via a placement Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$5,000,000 Immediately after the transaction No. of ordinary voting shares/units held: 30864197 (Direct Interest); 0 (Deemed Interest)The percentage of shareholding before the transaction is calculated based on the issued and paid-up share capital of the Listed Issuer of 546,605,998 ordinary shares (excluding treasury shares) as of 20 December 2021. The percentage of shareholding after the transaction is calculated based on the issued and paid-up share capital of the Listed Issuer of 577,470,195 ordinary shares (excluding treasury shares) after completion of the placement and issue of 30,864,197 ordinary shares in the capital of the Listed Issuer to Sian Chay Medical Institution on 21 December 2021, in accordance with the subscription agreement dated 13 December 2021 entered into between Sian Chay Medical Institution and the Listed Issuer. |
| 21/12/21 [21/12/21] |
Ng Tay Meng [SSH] | S/U | (0.000) | - | 27,386 | 4.74 | Note
Remarks
Issuance of 30,864,197 ordinary shares by the Company at an issue price of S$0.162 as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 27386455 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.74000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 546,605,998 shares and the percentage interest after the change was calculated based on 577,470,195 shares upon the issuance of 30,864,197 new ordinary shares as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of Asian Healthcare Specialists Limited (the "Company"). |
| 21/12/21 [21/12/21] |
Cheng Ching Li [SSH] | S/U | (0.000) | - | 49,311 | 8.54 | Note
Remarks
Issuance of 30,864,197 ordinary shares by the Company at an issue price of S$0.162 as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 49310528 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 8.54000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 546,605,998 shares and the percentage interest after the change was calculated based on 577,470,195 shares upon the issuance of 30,864,197 new ordinary shares as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of Asian Healthcare Specialists Limited (the "Company"). |
| 21/12/21 [21/12/21] |
AHS Investments Holdings Pte. Ltd. [SSH] | S/U | (0.000) | - | 243,100 | 42.09 | Note
Remarks
Issuance of 30,864,197 ordinary shares by the Company at an issue price of S$0.162 as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 235807000 (Direct Interest); 7293000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 40.83000000 (Direct Interest); 1.26000000 (Deemed Interest)AHS Investments Holdings Pte. Ltd. ("AHSIH") is deemed interested in 7,293,000 shares held by Dr. Lim Cheok Peng under a right of first refusal granted by Dr. Lim to AHSIH in respect of the 7,293,000 shares held by him. Accordingly, under Section 4 of the Securities and Futures Act ("SFA"), AHSIH is deemed interested in the shares held by Dr. Lim. The shareholders of AHSIH are Dr. Chin Pak Lin, Dr. Yue Wai Mun, Dr. Su Hsien Ching David and Dr. Tan Chyn Hong in equal proportions. Accordingly, each of Dr. Chin, Dr. Yue, Dr. Su and Dr. Tan is deemed interested in the shares that AHSIH is interested in by virtue of Section 4 of the SFA. The percentage interest before the change was calculated based on 546,605,998 shares and the percentage interest after the change was calculated based on 577,470,195 shares upon the issuance of 30,864,197 new ordinary shares as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of Asian Healthcare Specialists Limited (the "Company"). None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholders has been diluted. |
| 21/12/21 [21/12/21] |
Chin Pak Lin [SSH] | S/U | (0.000) | - | 243,100 | 42.09 | Note
Remarks
Issuance of 30,864,197 ordinary shares by the Company at an issue price of S$0.162 as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 42.09000000 (Deemed Interest)Please refer to paragraphs 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 21/12/21 [21/12/21] |
Su Hsien Ching David [SSH] | S/U | (0.000) | - | 243,100 | 42.09 | Note
Remarks
Issuance of 30,864,197 ordinary shares by the Company at an issue price of S$0.162 as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 42.09000000 (Deemed Interest)Please refer to paragraphs 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 21/12/21 [21/12/21] |
Tan Chyn Hong [SSH] | S/U | (0.000) | - | 243,100 | 42.09 | Note
Remarks
Issuance of 30,864,197 ordinary shares by the Company at an issue price of S$0.162 as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 42.09000000 (Deemed Interest)Please refer to paragraphs 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 21/12/21 [21/12/21] |
Yue Wai Mun [SSH] | S/U | (0.000) | - | 243,100 | 42.09 | Note
Remarks
Issuance of 30,864,197 ordinary shares by the Company at an issue price of S$0.162 as announced on 21 December 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 42.09000000 (Deemed Interest)Please refer to paragraphs 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 03/08/21 [30/07/21] |
Fullerton Fund Investments Pte Ltd ("FFI") [SSH] | S/U | (0.000) | - | 24,969 | 4.56 | Note
Remarks
Issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.56000000 (Deemed Interest)FFI does not have any direct interest in Shares. There is no change in the number of Shares in which FFI has a deemed interest. FFI is filing this notification form to report a change in the percentage level of its deemed interest in Shares from 5.27% to 4.56% as a result of the issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. FFI is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows. (i) Vanda 1 holds 1.14% of Shares. (ii) Encyclia 1 holds 3.42% of Shares. (iii) Heliconia Capital has an interest in 4.56% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1. (iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings. (v) Heliconia Holdings is a wholly owned subsidiary of Seletar. (vi) Seletar is a wholly owned subsidiary of FFI. Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. FFI is not involved in their business or operating decisions, including those regarding their positions in Shares. Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd. The percentage of interest immediately before the change is calculated on the basis of 473,633,025 Shares. The percentage of interest immediately after the change is calculated on the basis of 546,605,998 Shares. In this Notice, figures are rounded down to the nearest 0.01%. |
| 03/08/21 [30/07/21] |
Seletar Fund Investments Pte Ltd ("Seletar") [SSH] | S/U | (0.000) | - | 24,969 | 4.56 | Note
Remarks
Issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.56000000 (Deemed Interest)Seletar does not have any direct interest in Shares. There is no change in the number of Shares in which Seletar has a deemed interest. Seletar is filing this notification form to report a change in the percentage level of its deemed interest in Shares from 5.27% to 4.56% as a result of the issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Seletar is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows. (i) Vanda 1 holds 1.14% of Shares. (ii) Encyclia 1 holds 3.42% of Shares. (iii) Heliconia Capital has an interest in 4.56% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1. (iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings. (v) Heliconia Holdings is a wholly owned subsidiary of Seletar. Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. Seletar is not involved in their business or operating decisions, including those regarding their positions in Shares. Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd. The percentage of interest immediately before the change is calculated on the basis of 473,633,025 Shares. The percentage of interest immediately after the change is calculated on the basis of 546,605,998 Shares. In this Notice, figures are rounded down to the nearest 0.01%. |
| 03/08/21 [30/07/21] |
Temasek Holdings (Private) Limited ("Temasek") [SSH] | S/U | (0.000) | - | 24,969 | 4.56 | Note
Remarks
Issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.56000000 (Deemed Interest)Temasek does not have any direct interest in Shares. There is no change in the number of Shares in which Temasek has a deemed interest. Temasek is filing this notification form to report a change in the percentage level of its deemed interest in Shares from 5.27% to 4.56% as a result of the issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Temasek is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows. (i) Vanda 1 Investments Pte. Ltd. ("Vanda 1") holds 1.14% of Shares. (ii) Encyclia 1 Investments Pte. Ltd. ("Encyclia 1") holds 3.42% of Shares. (iii) Heliconia Capital has an interest in 4.56% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1. (iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings. (v) Heliconia Holdings is a wholly owned subsidiary of Seletar Fund Investments Pte Ltd ("Seletar"). (vi) Seletar is a wholly owned subsidiary of Fullerton Fund Investments Pte Ltd ("FFI"). (vii) FFI is a wholly owned subsidiary of Temasek. Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. Temasek is not involved in their business or operating decisions, including those regarding their positions in Shares. Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd. The percentage of interest immediately before the change is calculated on the basis of 473,633,025 Shares. The percentage of interest immediately after the change is calculated on the basis of 546,605,998 Shares. In this Notice, figures are rounded down to the nearest 0.01%. |
| 02/08/21 [30/07/21] |
Heliconia Capital Management Pte. Ltd. [SSH] | S/U | (0.000) | - | 24,969 | 4.57 | Note
Remarks
On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.57000000 (Deemed Interest)On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. The shareholding percentage immediately before the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 473,633,025 shares. The shareholding percentage immediately after the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 546,605,998 shares. |
| 02/08/21 [30/07/21] |
Heliconia Holdings Pte. Ltd. [SSH] | S/U | (0.000) | - | 24,969 | 4.57 | Note
Remarks
On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.57000000 (Deemed Interest)On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. The shareholding percentage immediately before the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 473,633,025 shares. The shareholding percentage immediately after the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 546,605,998 shares. |
| 30/07/21 [30/07/21] |
Ng Tay Meng [SSH] | S/U | 12,191 | 0.185 | 27,386 | 5.01 | Note
Remarks
Allotment and issuance of 12,190,585 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Ng Tay Meng for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction No. of ordinary voting shares/units held: 27386455 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.01000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company. |
| 30/07/21 [30/07/21] |
Khoo Shih Wee @ Lawrence Khoo [SSH] | S/U | 14,155 | 0.185 | 31,799 | 5.82 | Note
Remarks
Allotment and issuance of 14,154,738 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Lawrence Khoo for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction No. of ordinary voting shares/units held: 31798975 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.82000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in Asian Healthcare Specialists Limited's (the "Company") subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company. |
| 30/07/21 [30/07/21] |
Ho Siew Hong [SSH] | S/U | 18,189 | 0.185 | 41,267 | 7.55 | Note
Remarks
Allotment and issuance of 18,189,305 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Ho Siew Hong for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction No. of ordinary voting shares/units held: 41267103 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 7.55000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company. |
| 30/07/21 [30/07/21] |
Lim Tet Chen Roy [SSH] | S/U | (0.000) | - | 35,923 | 6.57 | Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction No. of ordinary voting shares/units held: 35922857 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 6.57000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company. |
| 30/07/21 [30/07/21] |
AHS Investments Holdings Pte. Ltd. [SSH] | S/U | (0.000) | - | 243,100 | 44.47 | Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction No. of ordinary voting shares/units held: 235807000 (Direct Interest); 7293000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 43.14000000 (Direct Interest); 1.33000000 (Deemed Interest)AHS Investments Holdings Pte. Ltd. ("AHSIH") is deemed interested in 7,293,000 shares held by Dr. Lim Cheok Peng under a right of first refusal granted by Dr. Lim to AHSIH in respect of the 7,293,000 shares held by him. Accordingly, under Section 4 of the Securities and Futures Act ("SFA"), AHSIH is deemed interested in the shares held by Dr. Lim. The shareholders of AHSIH are Dr. Chin Pak Lin, Dr. Yue Wai Mun, Dr. Su Hsien Ching David and Dr. Tan Chyn Hong in equal proportions. Accordingly, each of Dr. Chin, Dr. Yue, Dr. Su and Dr. Tan is deemed interested in the shares that AHSIH is interested in by virtue of Section 4 of the SFA. The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in Asian Healthcare Specialists Limited's (the "Company") subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted. |
| 30/07/21 [30/07/21] |
Chin Pak Lin [SSH] | S/U | (0.000) | - | 243,100 | 44.47 | Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 30/07/21 [30/07/21] |
Su Hsien Ching David [SSH] | S/U | (0.000) | - | 243,100 | 44.47 | Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 30/07/21 [30/07/21] |
Tan Chyn Hong [SSH] | S/U | (0.000) | - | 243,100 | 44.47 | Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 30/07/21 [30/07/21] |
Yue Wai Mun [SSH] | S/U | (0.000) | - | 243,100 | 44.47 | Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 30/07/21 [30/07/21] |
Cheng Ching Li [DIR] | S/U | 21,950 | 0.185 | 49,311 | 9.02 | Note
Remarks
Allotment and issuance of 21,949,690 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Cheng Ching Li for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction No. of ordinary voting shares/units held: 49310528 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 9.02000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company. |
| 26/04/21 [26/04/21] |
Ho Siew Hong [SSH] | S/U | (0.000) | - | 23,078 | 4.87 | Note
Remarks
Issuance of 17,700,000 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 23077798 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.87000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 455,933,025 shares and the percentage interest after the change was calculated based on 473,633,025 shares upon the issuance of 17,700,000 new ordinary shares as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted. |
| 26/04/21 [26/04/21] |
Cheng Ching Li [SSH] | S/U | (0.000) | - | 27,361 | 5.78 | Note
Remarks
Issuance of 17,700,000 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 27360838 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.78000000 (Direct Interest); 0.00000000 (Deemed Interest)The percentage interest before the change was calculated based on 455,933,025 shares and the percentage interest after the change was calculated based on 473,633,025 shares upon the issuance of 17,700,000 new ordinary shares as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted. |
| 26/04/21 [26/04/21] |
AHS Investments Holdings Pte. Ltd. [SSH] | S/U | (0.000) | - | 243,100 | 51.33 | Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 235807000 (Direct Interest); 7293000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 49.79000000 (Direct Interest); 1.54000000 (Deemed Interest)AHS Investments Holdings Pte. Ltd. ("AHSIH") is deemed interested in 7,293,000 shares held by Dr Lim Cheok Peng under a right of first refusal granted by Dr Lim to AHSIH in respect of the 7,293,000 shares held by him. Accordingly, under Section 4 of the Securities and Futures Act ("SFA"), AHSIH is deemed interested in the shares held by Dr Lim. The shareholders of AHSIH are Dr Chin Pak Lin, Dr Yue Wai Mun, Dr Su Hsien Ching David and Dr Tan Chyn Hong in equal proportions. Accordingly, each of Dr Chin, Dr Yue, Dr Su and Dr Tan is deemed interested in the shares that AHSIH is interested in by virtue of Section 4 of the SFA. The percentage interest before the change was calculated based on 455,933,025 shares and the percentage interest after the change was calculated based on 473,633,025 shares upon the issuance of 17,700,000 new ordinary shares as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of Asian Healthcare Specialists Limited (the "Company"). None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted. |
| 26/04/21 [26/04/21] |
Chin Pak Lin [SSH] | S/U | (0.000) | - | 243,100 | 51.33 | Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 51.33000000 (Deemed Interest)Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| 26/04/21 [26/04/21] |
Su Hsien Ching David [SSH] | S/U | (0.000) | - | 243,100 | 51.33 | Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 51.33000000 (Deemed Interest)Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above. |
| * | DIR - Director (include Directors of related companies) SSH - Substantial Shareholder COY - Company Share Buyback TMRP - Trustee-Manager/Responsible Person |
| ** | S - Shares W - Warrants U - Units R - Rights |
| *** | Direct & Deemed Interests |
Notes
- Only trades by directors, substantial shareholders and company share buy back are included in Insider Trades.